First look at how kidneys process experimental heart drug
NCT ID NCT05489614
Summary
This early study tested how a single dose of an experimental drug called olpasiran behaves in people with different levels of kidney function. It involved 33 adults, some with healthy kidneys and others with mild to severe kidney problems, including some on dialysis. The main goal was to understand how the drug's levels in the body change based on kidney health and to check for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Pharma CR, LLC
Miami, Florida, 33147-4040, United States
-
CRSCA HC LLC, dba Creekside Post Acute
Yucaipa, California, 92399, United States
-
Clinical Pharmacology Of Miami, LLC
Miami, Florida, 33014, United States
-
Inland Empire Clinical Trials, LLC
Rialto, California, 92377-4697, United States
-
Nucleus Network - Minneapolis
Saint Paul, Minnesota, 55114, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
Conditions
Explore the condition pages connected to this study.